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Background: Hypertension, stroke and coronary heart disease (CHD) are common diseases that impose a heavy
burden on patients and their families, particularly on those living in poor areas. This study examined catastrophic
medical payments faced by patients with these diseases and the effectiveness of the new rural cooperative medical
system (NRCMS) at alleviating the impact of the said diseases in fourth-class rural areas (i.e. those with annual
income of less than RMB1500/$240.2 per capita) of China.
Methods: Data on medical payments, including out-of-pocket and NRCMS-reimbursed expenses were collected
through self-administered questionnaires. The pre- and post-reimbursement (via the NRCMS) prevalence of
household poverty, catastrophic medical payment (CMP) incidence (Hcat), mean CMP gap (Gcat), mean positive CMP
gap (MPGcat) and other determinants of CMP incidence were identified.
Results: Out-of-pocket payments for treatment of hypertension, stroke and CHD averaged RMB580.1/$92.9,
RMB3028.4/$484.8 and RMB1561.4/$250.0 per capita, respectively, in 2008. Hcat, Gcat and MPGcat due to the three
diseases were 17.0%, 16.6% and 97.6%, respectively, and reimbursement through the NRCMS reduced them to
13.5%, 11.8% and 87.4%, respectively. The difference between pre- and post-reimbursement Hcat was not statistically
significant. After adjusting the covariates for age [OR = 1.87, 95% confidence interval (CI) = 1.19-2.95], education
(OR = 1.56, 95% CI = 1.07-2.27), marital status (OR = 1.67, 95% CI = 1.11-2.51), occupation (OR = 1.96, 95% CI = 1.34-2.85),
annual income (OR = 4.95, 95% CI = 3.28-7.48), the multiple logistic regression analysis revealed that patients with stroke
(OR = 3.94, 95% CI = 2.38-6.51) or CHD (OR = 2.25, 95% CI = 1.38-3.65) were more susceptible to CMP compared with
patients with hypertension only.
Conclusions: Out-of-pocket medical spending on hypertension, stroke and CHD imposes a heavy financial burden
on the residents of fourth-class rural areas of China. The NRCMS has some impact on reducing catastrophic
medical payments associated with these diseases, but improvement of the reimbursement rate is necessary to
further improve its effectiveness.
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Hypertension is a highly prevalent disease associated
with increased risk of cardiovascular diseases and high
mortality rates worldwide. For this reason, it is one of the
major public health concerns not only in the West but also
in the Asia Pacific region [1]. Occurrence of hypertension
among Chinese adults is on the rise due to economic devel-
opment and concomitant changes in lifestyle, particularly
in their diet. Between 2000 and 2001, 27.2% of Chinese
adults aged 35 to 74 years, or about 129,824,000 individ-
uals, had hypertension [2]. In 2002, 18% of adults aged
18 years and above, or about 153 million of the Chinese
population, reportedly had hypertension [3]. Hypertension
is also a major risk factor for stroke, coronary heart disease
(CHD), heart failure, myocardial infarction and other
serious cardiovascular and chronic kidney diseases. In
a prospective cohort study involving 169,871 Chinese
men and women aged 40 years and above, Gu et al.
found a strong, linear and independent relationship be-
tween blood pressure levels and the risk of cardiovas-
cular diseases in Chinese adults [4].
Providing clinical care for hypertension and its complica-
tions imposes great economic burden on patients as well as
the country. According to the Chinese Third National
Health Services Survey conducted in 2003, direct medical
spending on outpatient services averaged RMB72.4/$11.6,
RMB215.4/$34.5, and RMB177.3/$28.4 for each visit associ-
ated with hypertension, stroke, and CHD, respectively, in
rural areas. Furthermore, direct medical spending on in-
patient services averaged RMB1329.6/$212.9, RMB2799.1/
$448.1, and RMB2108.4/$337.6 for each visit associated
with hypertension, stroke, and CHD, respectively, in rural
areas [5]. Lloyd-Jones et al. estimated the cost of hyperten-
sion in the US at $73.4 billion in 2009 [6]. According to
Zhai et al., the direct medical costs of Chinese patients aged
35 to 74 years with hypertension, CHD and stroke in 2003
were RMB20.2/$3.23, RMB15.7/$2.51, and RMB24.3/3.89
billion, respectively. Similarly, medical cost attributed to
hypertension was estimated at RMB19.1 billion/$3.06
billion, which accounts for 47.7% of the total medical
cost of treatment of stroke and CHD [7].
Health spending is considered to be catastrophic when
a household must reduce its basic expenditure over a
period of time to cope with health costs, but there is no
consensus on the threshold [8]. Therefore, catastrophic
medical payment (CMP) reflects a household’s payment
capacity. If a family’s out-of-pocket (OOP) health expend-
iture exceeds its total disposable income for a certain period
by 30% or more, then the family is considered to be fa-
cing CMP. According to a report by Xu et al., in which
a threshold of 40% was used, the incidence of CMP
varies across countries; it is low in developed countries
(e.g., 0.57% in Switzerland and 0.55% in the US) and
high in countries experiencing economic transitions(e.g., 7.50% in Azerbaijan and 10.45% in Vietnam) [9].
Himmelstein found that CMP incidence is below 1% in
some countries, but as high as 13% in other countries
[10]. Notably, even wealthy families may be subjected
to CMP [10].
Out-of-pocket payments are the principal means of finan-
cing healthcare in China, which has led to high incidence
of CMP [11]. According to Li et al., rural households have
greater risk of incurring CMP than urban households [12].
Likewise, CMP is observed more frequently in households
located in poor areas than in those located in wealthy re-
gions [12]. Hence, in rural China, particularly in the poorest
regions with annual income of no more than RMB1500/
$240.2 per capita, medical expenditure is an important
cause of transient poverty [13]. Members of poor families
usually suffer from chronic diseases such as hypertension
and CHD that constitute the main reason for sickness
poverty. According to the Third National Health Services
survey conducted in China in 2003, the prevalence of
common chronic diseases in rural areas was 12.6% [5].
Similarly, according to a study conducted by Ma et al. in
southwest China, approximately 38.8% of poor rural fam-
ilies were victimized by chronic illnesses, with significantly
higher proportion of impoverished families affected com-
pared to non-impoverished families [14]. Ying et al. found
that the mean self-paid (i.e. OOP) medical cost of poor
families is RMB1414/$ 226.4 per month, which accounts
for 70% of their average monthly expenditure [15]. In the
case of a major illness, poor families may give up treat-
ment or cut down their budget for other living necessities
(e.g., food, clothing, housing and children’s education)
and/or borrow money to afford medical costs, thereby
increasing the severity of their poverty [16].
The three key prerequisites for CMP are poor access to
health services, expensive medical costs and lack of health
insurance [9]. Ramses and Karine Lamiraud pointed out
that expanding the coverage of the medical insurance sys-
tem could reduce the incidence of CMP [17]. To prevent
the phenomenon of ‘poverty due to illness’ in rural China,
the New Rural Cooperative Medical System (NRCMS)
was introduced to rural health sectors in 2003. NRCMS is
financed by combined contributions from central and
local government bodies and from individual households
[18]. NRCMS operates at the county level. Counties deter-
mine the deductible, ceiling, reimbursement ratio, medical
saving account (MSA). The ministry of health of central
and local government agencies is the policy maker and
mainstay of NRCMS. Central and local governments
initially contributed RMB40/$6.4 for each enrollee an-
nually since 2003, whereas participants only contributed
RMB10/$1.6. This criterion doubled both for central
and local governments and individual participants in 2008.
In practice, NRCMS reimburses approximately 30% of
inpatient expenditures [19,20]. There are essentially
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NRCMS. The most common model (especially in the
western and central regions) is implemented in 47% of
Chinese counties. This model involves formula-based
reimbursement of inpatient services and the use of
MSA for reimbursements of outpatient services and
preventive care. Household are expected to make con-
tribution to MSAs, and household members can use
the MSA for outpatient services. A second model is
similar (applied in some 41% of Chinese counties). It
uses the same inpatient reimbursement policy, but there is
no MSA. Use of these two models has changed rapidly,
reflecting the policy to phase out MSAs gradually over
time. In 2007, for example, nearly two-thirds of counties
used the first model and 7% used the second. Outpatient
services and preventive care can be reimbursed from
pooled funds, and is subject to a formula but usually
involves no deductible. The third model (applied in
about 8% of Chinese counties) reimburses both inpatient
and outpatient services for catastrophic diseases, with
separate deductibles and reimbursement caps. The fourth
model used in 4% of Chinese counties reimburses both in-
patient and outpatient services from pooled funds. All four
models emphasize reimbursement for inpatient services,
which are subject to deductibles and caps. Inpatient deduct-
ibles were RMB100 (range 0–200)/$16.0 (range 0–32.0),
RMB250 (range 0–500)/$40.0 (range 0–80.0), and RMB800
(range 0–2000)/$128.1 (range 0–320.0) at township, county,
and provincial hospitals, respectively. The average reim-
bursement ceiling was RMB30,000 (range 8,000-180,000)/
$4803.0 (range 1280.8-28818) for inpatient care [19].
By the end of September 2008, more than 95% of
counties in China were covered by the program [21].
The NRCMS has become one of three major medical
insurances in the country, with rural residents covered by
the NRCMS, urban employees under the Urban Employees
Basic Medical Insurance and unemployed urban residents
under the Urban Residents Basic Medical Insurance.
The main goal of the NRCMS is to improve access of
rural residents to health services and, above all, to help
them reduce the risks that accompany catastrophic ill-
nesses, thereby protecting them from impoverishment
caused by CMP [22,23].
The present study examines the incidence and severity
of catastrophic medical payments due to hypertension,
stroke and CHD, and identifies the role of the NRCMS
in alleviating CMP-induced poverty in four poor rural
counties in central and western China.
Methods
Face-to-face interviews were conducted on patients with
hypertension and/or stroke and CHD in the Hong Kong
Kadoorie Project. Self-administrated questionnaires were
used to collect data on medical payments, includingout-of-pocket (OOP) and NRCMS-reimbursed expenses.
The pre- and post-reimbursement (via the NRCMS) preva-
lence of household poverty, catastrophic medical payment
(CMP) incidence (Hcat), mean CMP gap (Gcat), mean posi-
tive CMP gap (MPGcat) and other determinants of CMP
incidence were calculated.
The research protocol was approved by the Ethics
Committee of Tongji Medical College, Huazhong University
of Science and Technology (IRB No: FWA000007304).
Informed consents were obtained from all participants
prior to collection of the data.
Study area and subjects
The research was conducted based on data collected
from an investigation carried out between October 15
and October 30 in 2009. The investigation took place in
areas where hypertension patients were all involved in
the Hong Kong Kadoorie Project of ‘Community Health
Promotion in Poor Rural Areas of China’, which funds
the systematic management of prevalent hypertension
and its complications in rural districts of central and
western China. Under the Kadoorie Project, local general
practitioners are trained to diagnose hypertension and
its complications, perform regular interviews, provide
guidelines for drug use and offer health education pro-
grams to patients. This project differs from health insur-
ance (e.g., NRCMS) and does not provide the patients
with any economic help. A total of 10 towns—three in the
Ledu county of Qinghai Province, three in the Hezheng
county of Gansu Province, one in the Jiaocheng county
and three in the Pinglu county of Shanxi Province—were
involved in this investigation. All of them were classified
as fourth-class rural areas where the average annual in-
come was less than RMB1500/$240.2 per capita in 2003.
In other words, these rural areas have the worst economic
level among all Chinese rural districts [13]. At the time of
the investigation, the four counties (i.e. Ledu, Hezheng,
Jiaocheng and Pinglu) had total populations of 209,046,
166,586, 158,331 and 213,912, respectively, and an average
annual income of RMB3130/$501.1, RMB1727/$276.5,
RMB2920/$467.5 and RMB1440/$230.5 per capita, respect-
ively. Cluster sampling strategy was used to randomly select
two villages in each of the 10 towns.
All of the 1528 hypertension patients in the 20 selected
villages were involved in the Kadoorie Project. According
to the reported 12.6% prevalence of hypertension among
adults aged 18 years or above in fourth-class rural regions,
about 2500 prevalent hypertension cases existed in all of
the 20 villages (with a total of 20,000 adults aged 18 years
or above) [24]. However, some of the patients had left
their hometown for residence or work in other cities. Only
1528 hypertension patients were left in the study area, and
only 1262 of them from 1176 households participated
in our investigation. The other 266 patients were not
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home for work and inconvenient communication. More
than 95% of the rural residents in the selected areas were
NRCMS participants.
In this study, hypertension was defined as systolic
blood pressure of ≥ 140 mmHg, diastolic blood pressure
of ≥ 90 mmHg and/or a self-reported current treatment
for hypertension. All subjects were aged 21 to 90 years
(with a mean of 61.2 years) and were diagnosed with
hypertension by a physician in township health centres
or reputed hospitals. The respondents consisted of 1000
patients with hypertension from 947 families, 112 patients
with stroke from 110 families, and 150 patients with CHD
from 149 families. Patients who were suffering from sec-
ondary hypertension were excluded from the count.
Data collection
Self-administered questionnaires were used for collect-
ing data on sociodemographic characteristics including
gender, age, nationality (i.e. Han or others such as
Hui, Uygur, Dongxiang, Tujia or Kazak), marital status
(i.e. married, divorced, widowed or unmarried), educational
background (i.e. elementary, middle or senior middle
school), occupation (i.e. farming or non-farming), and
family status (i.e. general or enjoying five guarantees
(i.e. childless and infirm; old persons who are guaran-
teed food, clothing, medical care, housing and burial
expenses by communes; low-income families)), household
income and household medical expenditures for treat-
ment of hypertension, stroke, CHD and other diseases
(including costs of outpatient and inpatient services)
that were disbursed through either OOP or the NRCMS
(reimbursement) in the preceding year (i.e. 2008). The
economic status of households was evaluated by com-
paring the annual per capita income with the poverty
line of RMB1300/$208.1 per capita set by the Chinese
State Council Poverty Alleviation Leading Group Office;
a poor economic status indicates an annual per capita
income below the threshold, and a non-poor economic
status indicates an annual per capita income equal to or
above the threshold.
Most of the participants were recruited to the village
health care centres by local general practitioners. Face-to-
face interviews were conducted by trained investigators. All
completed questionnaires were returned on the spot. Some
of the participants who experienced difficulties in walking
received the interview and completed the questionnaire at
their own homes with the help of our investigators.
Data analysis
Prevalence of household poverty
The Chinese State Council Poverty Alleviation Leading
Group Office set the poverty line at an annual income of
RMB1300/$208.1 per capita. Families with income lessthan this amount are considered poverty-stricken fam-
ilies in the present study. The prevalence of household
poverty (Hpov) was calculated using the formula below,
where N represents the sample size of families and P is
designated a value of 0 or 1, which indicates whether a





A household’s poverty status can be evaluated by Hpov.
Impoverishment (expressed as HH-pov) as a result of
health costs related to hypertension, stroke or CHD was
estimated by subtracting the medical costs prior to
NRCMS reimbursements from the household income.
Thus, the difference between Hpov and HH-pov indicates
the extent to which the health costs of the studied diseases
impoverish the households. HH-pov was also calculated after
the NRCMS reimbursements. The role of the NRCMS in
alleviating impoverishment induced by the studied diseases
can thus be evaluated quantitatively using the difference
between pre- and post-reimbursement (via the NRCMS)
HH-povs.
Incidence and severity of catastrophic medical payments
The incidence and intensity of CMP were measured as de-
scribed previously by Wagstaff and van Doorslaer MP [25].
An OOP medical payment is considered financially
catastrophic when it is large relative to the household’s
ability to pay (e.g., exceeding 15% of the family income)
[8]. Thresholds of 10%, 20%, 30%, 40%, 50% and 60% of
household capacity to pay (CTP) were used to define
CMP. In this study, a threshold of 40% was adopted [8].
The World Bank and the WHO define CTP as the house-
hold’s disposable income calculated as the total income
minus subsistence expenditure [25]. CTP can be evaluated
based on household consumption, expenditure, income or
wealth index. Household income was used to evaluate
CTP in this study. In the following description, X repre-
sents CTP, T represents payments for healthcare and zcat
represents the threshold of CMP, which amounts to
40%. Oi is the catastrophic overshoot, which is equal
to Ti/xi-zcat if Ti/xi > zcat and to 0 if otherwise; Ei is
equal to 1 if Oi > 0 and to zero if otherwise.
CMP incidence describes the frequency of CMP in all
the studied households. It is calculated from the formula
below, where Hcat is the CMP incidence, and N is the





CMP incidence reflects the number of families with
catastrophic medical spending (i.e. the number of families
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threshold). However, it cannot represent how much a
given household pays beyond its CTP. Another parameter
of mean CMP gap was thus used to measure catastrophic
severity. The CMP gap describes how much of a house-
hold’s medical payment is in excess of the threshold of
40% of its CTP. The mean CMP gap can be calculated
from the equation below, where Gcat is the mean CMP





Gcat is estimated to reveal the average level of CMP se-
verity for all studied households, but it cannot indicate
to what extent excessive payments affect the said house-
holds. This value can be illustrated by the parameter
mean positive CMP gap (MPGcat), which refers to the
average excess payment made by households in the sam-









EpiData version 3.1 was used to manage all data.
Chi-squared test was used to analyse the demographics of
the subjects among the three groups (i.e. hypertension,
stroke, and CHD groups). Multiple logistic regression
analysis was performed with a multilevel model because
both individual- and family-level variables are potential
determinants of CMP incidence caused by hypertension,
stroke and CHD. Statistical analysis was conducted using
SAS version 8.12.
Results
Demographics and socio-economic status of the subjects
The demographics and socio-economic status of all the
subjects are shown in Table 1. The mean (SD) age of the
subjects was 61.2 (12.0) years. Among the subjects, 37.4%
were male (n = 472) and 62.6% were female (n = 790).
Most of them (90.1%) were of Han ancestry. The average
annual income of the subjects was RMB2263.7/$362.4 per
capita. About 42.5% of the subjects came from families
that were below the poverty line set by the Chinese State
Council Poverty Alleviation Leading Group Office. Village
clinics (47.8%) and township health centres (47.7%), which
were about 30 minutes away from the residences of 85.3%
of the subjects, were the main and nearest providers of
medical care services. Over 98.9% of the subjects were
covered by a medical insurance system, and most of the
subjects (98.0%) took part in the NRCMS.Household expenditure on all health services
Household expenditures on health services by the subjects
are shown in Table 2. Poor families spent 32.0% of their
household income for health services, whereas non-poor
families spent only 23.5%. This difference is statistically sig-
nificant (χ2 = 13.82, P = 0.0002). In 2008, the mean health
cost of hypertension, stroke and CHD among poor families
was RMB873.1/$139.8 per capita, which was not signifi-
cantly lower than the RMB946.8/$151.6 spent by non-poor
families (χ2 = 0.72, P = 0.3971). Subjects from poverty-
stricken families were found to have mean expenditures
of RMB583.7/$93.5, RMB2808.4/$449.6 and RMB1153.4/
$184.7, which corresponded to 24.7%, 65.4% and 31.5% of
total household health expenditure, for hypertension,
stroke and CHD, respectively, in 2008. The corresponding
values for other subjects were RMB577.6/$92.5 (15.7%),
RMB3205.7/$513.2 (49.9%) and RMB1991.8/$318.9 (42.7%)
for hypertension, stroke and CHD, respectively. However,
the differences between poverty-stricken families and others
were not statistically significant.
Household poverty caused by out-of-pocket payments
related to hypertension, stroke and CHD
The results for families impoverished by costs related to
hypertension, stroke and CHD and the effects of NRCMS
reimbursement are shown in Table 3. The NRCMS man-
aged to decrease the poverty impact of OOP payments due
to hypertension, stroke and CHD to 1.2% (from 6.9%
pre-reimbursement to 5.7% post-reimbursement). The
Hpov values for families with hypertension, stroke or
CHD patients were not significantly different (χ2 = 5.636,
P = 0.060). The NRCMS managed to lower the poverty
impact of OOP payments due to hypertension to 0.4%
(from 4.7% to 4.3%), that due to stroke to 4.5% (from 6.4%
to 1.9%), and that due to CHD to 3.3% (from 13.4% to
10.1%). Hypertension, stroke and CHD are the major
chronic diseases that impoverish rural families in the study
areas. The NRCMS alleviated the financial burden of these
diseases on the households to some extent, but the effects
were statistically insignificant.
Incidence and severity of catastrophic medical payments
The results for incidence and severity of catastrophic
medical payments are shown in Table 4. The Hcat, Gcat
and MPGcat values of all the families were 44.4%, 66.4%
and 149.6%, respectively. The Hcat values of the poor and
non-poor families were 64.8% and 29.3%, respectively.
Poor families were more likely to be subjected to CMP
compared with non-poor families (χ2 = 146.82, P < 0.001).
The corresponding Gcat and MPGcat of the poor families
were 131.3% and 202.7%, respectively, whereas those of
the non-poor families were 18.4% and 62.9%, respectively.
Our findings on the incidence and severity of cata-
strophic medical payments associated with hypertension,
Table 1 Demographics and social economics of all subjects enrolled in the study
Variables Hypertension Stroke CHD Total Statistics
Family member aged 60 years or above Yes 638 91 117 846 χ2 = 22.97, P < 0.001
No 361 21 33 415
Family status General 924 90 139 1153 χ2 = 18.88, P < 0.001
Others† 76 22 11 109
Occupation Farming 562 60 102 724 χ2 = 8.15, P = 0.017
Non-farming 438 52 48 538
Economic status△ Non-poor 591 62 73 726 χ2 = 6.05, P = 0.049
Poor 409 50 77 536
Nearest medical centre Village clinic 462 48 97 607 P = 0.001 (Fisher)
Township health centre 485 60 47 592
County hospital 5 1 1 7
Personal clinic 48 3 5 56
Time spent travelling to the nearest medical centre Less than 30 min. 858 89 122 1069 P = 0.241 (Fisher)
30 min. to 60 min. 110 18 23 151
over 60 min. 32 5 5 42
Age Less than 60 years 485 23 50 558 χ2 = 40.11, P < 0.001
60 years and above 515 89 100 704
Gender Male 368 55 49 472 χ2 = 8.15, P = 0.017
Female 632 57 101 790
Race Han 909 105 123 1137 χ2 = 13.42, P = 0.001
Others‖ 91 7 27 125
Educational background Illiterate 350 51 64 465 χ2 = 7.28, P = 0.026
Others* 650 61 86 797
Marital status Married 820 85 112 1017 χ2 = 6.21, P = 0.045
Others※ 180 27 38 245
Medical insurance Yes 990 112 147 1249 P = 0.230 (Fisher)
No 10 0 3 13
†Households enjoying five guarantees (i.e. childless and infirm; old persons who are guaranteed food, clothing, medical care, housing and burial expenses by
communes; low-income families).
△The economic status of households was evaluated by comparing the annual per capita income with the poverty line of RMB1300/$208.1 per capita set by the
Chinese State Council Poverty Alleviation Leading Group Office; a poor economic status indicates an annual per capita income below the threshold, and a
non-poor economic status indicates an annual per capita income equal to or above the threshold.
‖Nationality of Hui, Uygur, Dongxiang, Tujia, or Kazak etc. except Han.
*Elementary, middle or senior middle school.
※Divorced, widowed or unmarried.
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to the costs related to the three diseases. The NRCMS
managed to lower CMP incidence to 13.5%. The represen-
tative Hcat values for hypertension, stroke and CHD were
12.4%, 40.9% and 26.8%, respectively, and the NRCMS
lowered these values to 9.7%, 30.9% and 20.8%, respect-
ively. Thus, the NRCMS had an important role in easing
the economic pressure and decreasing the incidence and
severity of catastrophic medical payments caused by the
three diseases. However, the decrease in CMP incidence
produced by the NRCMS was fairly small. The Gcat and
MPGcat values associated with stroke were larger than
those associated with hypertension and CHD, suggestingthat stroke imposes a larger financial burden on families
than the other two diseases.
Influential factors associated with CMP incidence among
individuals
Multiple logistic regression analysis with forward selection
was used to determine the factors related to CMP incidence
resulting from hypertension, stroke or CHD among the
studied individuals. The outcome variable of this process
was the status of CMP incidence (yes or no), and the inde-
pendent variables included gender, age, race, educational
background, marital status, occupation, income, prevalent
disease (hypertension, stroke or CHD), time spent travelling
Table 2 Household health expenditures among the families of the subjects
Diseases Family type△ N* / Fa-N† HEHypD
‡ (RMB/$) HET
§ (RMB/$) HEHypD /HET (%) IHEHypD
|| (RMB/$)
Hypertension Non-poor 591/558 341356/54651 2175912/348364 15.7 577.6/92.5
Poor 409/389 238729/38221 966567/154747 24.7 583.7/93.5
Total 1000/947 580085/92872 3142479/503111 18.5 580.1/92.9
Stroke Non-poor 62/60 198754/31821 398600/63816 49.9 3205.7/513.2
Poor 50/50 140422/22482 214890/34404 65.4 2808.4/449.6
Total 112/110 339176/54302 613490/98220 55.3 3028.4/484.8
CHD Non-poor 73/73 145399/23278 340310/54484 42.7 1991.8/318.9
Poor 77/76 88812/14219 281700/45100 31.5 1153.4/184.7
Total 150/149 234211/37497 622010/99584 37.6 1561.4/250.0
Total Non-poor 724/684 685509/109750 2914822/466663 23.5 946.8/151.6
Poor 536/502 467963/74921 1463157/238494 32.0 873.1/139.8
Total 1262/1176 1153472/184671 4377979/713610 23.6 914.0/146.3
△A non-poor family type has an annual income of RMB1300/$208.1 per capita or above; a poor family type has an annual income of less than RMB1300/ $208.1
per capita.
*N indicates the number of subjects studied.
†Fa-N indicates the number of families of the subjects.
‡HEHypD indicates the household expenditure related to hypertension, stroke and CHD among the studied families in the past year (2008).
§HET indicates the total household health expenditures of the studied families in the past year (2008).
||IHEHypD indicates individual health expenditures related to hypertension, stroke and CHD in the past year (2008).
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the nearest medical centre. The results are shown in Table 6.
The following subjects were greatly susceptible to
CMP, as seen in their corresponding representative ORs
(95% CIs): those aged 60 years or above (relative to those
aged 60 years and below), 1.87 (1.9-2.95); those with no
educational background (relative to the non-illiterate), 1.56
(1.07-2.27); those whose marital status was divorced,
widowed or unmarried (relative to married participants),
1.67 (1.11-2.51); those with a non-farming occupation
(relative to those with a farming occupation), 1.96
(1.34-2.85); those with an annual income of less than
RMB1300/$208.1 per capita (relative to those with an
annual income of RMB1300/$208.1 or above per capita),
4.95 (3.28-7.48); those suffering from stroke (relative to
those suffering from hypertension only), 3.94 (2.38-6.51);
those suffering from CHD (relative to those suffering from
hypertension only), 2.25 (1.38-3.65).Table 3 Prevalence (%) of fundamental poverty and the pre-
caused by medical payments for hypertension, stroke and CH
Variables Hypertension (n = 947) Stroke (n = 11
Hpov 40.9 44.5
Pre-reimbursement HH-pov 45.6 60.9
Post-reimbursement HH-pov 45.2 56.4
Declines 0.4 4.5
Statistics^ χ2 = 0.019, P = 0.890 χ2 = 0.334, P = 0.
#The Pearson chi-squared test was used to compare the incidence of household po
and CHD.
^The Pearson chi-squared test was used to compare the incidence of household poDiscussion
Rural households in central and western China, particularly
those below the poverty line, are always susceptible to
disease-induced poverty [13]. Even a fairly small medical
cost can be catastrophic for them. According to our find-
ings, poor families (i.e. those with an average income of less
than RMB1300/$208.1 per capita in 2008) had smaller med-
ical expenditures related to hypertension, stroke and CHD
in 2008 than non-poor families (i.e. those with an average
income of RMB1300/$208.1 or above per capita in 2008). In
addition, the proportion of health costs to total household
health expenditure for hypertension, stroke and CHD was
significantly higher in the former than in the latter. Of the
three diseases we focused on, we found stroke to incur the
largest medical expenditures, which is consistent with a
previous report by Zhai et al. [7].
Over 40% (44.4%) of the families were found to have
suffered from catastrophic medical payments, with a Gcatand post-reimbursement (via the NRCMS) impoverishment
D among the families under review
0) CHD (n = 149) Total (n = 1176) Statistics#
51.0 42.5 χ2 = 5.636, P = 0.060
64.4 49.4 χ2 = 24.712, P < 0.001
61.1 48.2 χ2 = 16.251, P < 0.001
3.3 1.2
563 χ2 = 0.469, P = 0.494 χ2 = 0.359, P = 0.549
verty among families with members suffering from hypertension, stroke
verty before and after NRCMS reimbursement.
Table 6 Results of the multiple logistic regression analysis
determining the factors associated with the post-
reimbursement (via the NRCMS) CMP incidence caused by
medical payments for hypertension, stroke or CHD*
Variables Values OR (95% CI) P
Age 60 years or below 1




Illiterate 1.56 (1.07, 2.27) 0.0214
Marital status Married 1
Divorced, widowed
or unmarried
1.67 (1.11, 2.51) 0.0145
Occupation Farming 1
Non-farming 1.96 (1.34, 2.85) 0.0004
Annual income RMB1300/$208.1





4.95 (3.28, 7.48) <0.0001
Disease Hypertension 1
Stroke 3.94 (2.38, 6.51) <0.0001
CHD 2.25 (1.38, 3.65) 0.0011
*-2 Log L (intercept and covariates) = 783.026; R-square = 0.1226; max-rescaled
R-square = 0.2320; Wald chi-square = 129.56, P < 0.001; Deviance value = 459.8351
(df = 527), P = 0.9839; Pearson value = 633.3337 (df = 527), P = 0.0010.
Table 4 Results of the incidence and severity of catastrophic
medical payments among all the studied families
Variables Poor families† Non-poor families‡ Total
N. of family* 324 198 522
Hcat (%)
# 64.8 29.3 44.4
Gcat (%) 131.3 18.4 66.4
MPGcat (%) 202.7 62.9 149.6
†Poor families indicate those with an annual income of less than
RMB1300/$208.1 per capita.
‡Non-poor families indicate those with an annual income of RMB1300/$208.1
per capita or above.
*N. of family indicates the number of families with CMP.
#Statistics: χ2 = 146.82, P < 0.001.
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cluded in the study had significantly higher CMP incidence,
Gcat and MPGcat than non-poor families. According to our
investigation, some of the families enduring CMP needed
to sell personal items to pay for their health expenditures
(data not shown). Hypertension, stroke and CHD were also
discovered to be important causes of CMP. CMP incidence
resulting from these diseases was 17.0%, which was lowered
to 13.5% via NRCMS reimbursement. Moreover, Gcat and
MPGcat were 16.6% and 97.6%, respectively, and dropped
to 11.8% and 87.4%, respectively, after NRCMS reimburse-
ment. In addition, the NRCMS managed to curtail the
poverty impact of OOP payments due to hypertension,
stroke and CHD to 1.2% (from 6.9% pre-reimbursement to
5.7% post-reimbursement). Thus, our findings showed that
NRCMS reimbursements led to small decreases in the inci-
dence and severity of catastrophic medical payments for
hypertension, stroke and CHD, which suggests that the
NRCMS plays a limited role in alleviating CMP-induced
poverty among poor rural families [26].
The NRCMS policy focuses mainly on decreasing OOP
payments for inpatient services to provide rural residents,
particularly the disadvantaged ones, with easy access to
health services and to reduce household risk of cata-
strophic medical payments resulting from major diseases.
Thus, inpatient service utilisations increased under theTable 5 Results of the pre- and post-reimbursement
(via the NRCMS) catastrophic medical payments related
to hypertension, stroke and CHD
Variables Hypertension Stroke CHD Total
N. of
families*
114 vs 92 45 vs 34 40 vs 31 199 vs 157
Hcat (%) 12.4 vs 9.7 40.9 vs 30.9 26.8 vs 20.8 17.0 vs 13.5
Gcat (%) 7.4 vs 5.3 77.3 vs 58.8 25.4 vs 15.1 16.6 vs 11.8
MPGcat (%) 61.6 vs 54.6 190.4 vs 188.9 94.8 vs 72.6 97.6 vs 87.4






*N. of families indicates the number of families with CMP for
hypertensive diseases.
#The Pearson chi-squared test was used to compare Hcat before and after the
NRCMS reimbursement for the medical costs related to the studied diseases.NRCMS, whereas outpatient service utilisations did not
[27,28]. According to our investigation (data not shown),
the OOP costs of outpatient service constituted a lar-
ger part (mean of 85.8%) of the total medical costs of
hypertension, stroke, and CHD, compared with that of
inpatient service (mean of 14.2%). Moreover, the NRCMS
reimbursement rate to outpatient service averaged
7.3% (median 0.0%, and range 0–100.0%) and 54.6%
(median 60.0%, and range 0–100.0%) for the 1005 patients
receiving outpatient services and the 207 patients receiving
inpatient services, respectively, for hypertension, stroke,
and CHD in the past one year (i.e. 2008). Additionally,
approximately 73.9% of the participants reported medical
costs almost equal to or beyond their acceptable level in
our research (data not shown). Thus, our findings suggest
that the NRCMS did not sufficiently relieve poverty
caused mainly by the purchase of anti-hypertension drugs,
which is highly prevalent in outpatient services. Moreover,
the goal of the NRCMS to provide insurance for rural resi-
dents against catastrophic illnesses has not been achieved
[29]. The present proportion of OOP medical payments is
fairly high for rural households in China [30]. Since most
health payments in China comprise high percentages of
OOP payments, China is more susceptible to CMP than
other countries. CMP is highly unlikely to occur in families
with OOP health payments lower than 15% [31].
Poverty among rural families also merits close attention.
CMP is not caused simply by expensive medical procedures
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a financial catastrophe to poor households, forcing them to
cut down their budget for basic expenses such as food,
shelter or children’s education [32]. Local poverty may lead
to decrease in the number of people who seek medical care
when they are sick and may subsequently affect accessibility
of health services [16]. Many studies have shown that CMP
is very likely to occur in households with poor economic
conditions [9,33-35]. The results of our logistic regression
analysis show that household economic conditions are as-
sociated with CMP incidence, i.e. poor families are more
likely to be subjected to CMP compared with non-poor
families. Prevention of CMP can therefore lead to increase
in the income of rural households, particularly of poor
ones. Poor households can be protected from CMP by
reducing the reliance of the health system on OOP
costs, providing them with additional financial security,
such as medical finance assistance, and increasing the
reimbursement rate of the NRCMS.
Stroke and CHD are common complications of hyper-
tension. Unlike patients suffering from hypertension
only, patients with stroke or CHD are very susceptible
to CMP. Therefore, prevention of hypertension compli-
cations is also necessary to decrease CMP incidence.
Lowering the price of anti-hypertension drugs may make
the drugs accessible to patients and in turn decrease
their risk for hypertension-related complications.
Medical insurance was not found to be associated with
CMP, indicating that NRCMS reimbursements do not
efficiently decrease the impacts of OOP costs of hyper-
tension, stroke and CHD on patients. Furthermore, the
low reimbursement rate of outpatient services may
also be a point of concern.
Given the possibility of catastrophic effects of medical
payments for hypertension, stroke and CHD on the fi-
nancial conditions of patients, a better mechanism for
implementation of NRCMS is needed to improve the
reimbursement procedures for inpatient services and
drug purchase, and to lower the burden of OOP costs
on patients. Prevention and control of hypertension
and its complications is a major public health issue. To
some extent, the present NRCMS and Medical Assistance
Policy have benefited hypertension patients and re-
duced the risk of consequential poverty among rural
families in China. However, the benefits for poor
households with patients suffering from chronic diseases
(e.g., hypertension and its complications) seem very small.
To achieve its goal of decreasing impoverishment caused
by treatment costs for hypertension and its complications,
the NRCMS should consider providing additional or
even full payment. In some areas across China, a mode
of secondary reimbursement of medical costs has been
extended to poor patients suffering from hypertension
or its complications. However, this is just a temporarysolution and more needs to be done to achieve the goal
of drastically reducing CMP incidence.
A major limitation of our study is the conservative
extensionality of the conclusions we reached. As mentioned
above, our study was conducted on subjects who are part
of the project ‘Community Health Promotion in Poor Rural
Areas of China’. Subjects suffering from hypertension or its
complications are systematically managed in the project, so
they do not constitute a representative sample. In this light,
our findings should be interpreted cautiously. The skewed
gender distribution (37.40% males versus 62.60% females)
of the subjects in our study is also notable because
most male adults leave their poor rural hometowns for
high-paying jobs in cities, whereas most women stay at
home looking after their children and elders. This
phenomenon is common in most poor rural areas of
central and western China.
Conclusions
Out-of-pocket payments for treatment of hypertension,
stroke and CHD impose a heavy burden on households
in fourth-class rural areas of China. The NRCMS policy
is somewhat effective at preventing disease-induced
poverty among poor rural households in China, but
needs to be revised by improving the reimbursement
rate in order to produce better outcomes.
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